United Therapeutics
UTHR
#957
Rank
A$37.02 B
Marketcap
A$869.25
Share price
-0.32%
Change (1 day)
20.33%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): A$41.73

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is A$42.44. In 2025 the company made an earnings per share (EPS) of A$44.77 an increase over its 2024 EPS that were of A$39.24.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$41.73-6.8%
2025A$44.7714.1%
2024A$39.2425.59%
2023A$31.2431.54%
2022A$23.7551.18%
2021A$15.71-9.1%
2020A$17.28-581.4%
2019A-$3.59-117.79%
2018A$20.1742.11%
2017A$14.20-40.93%
2016A$24.0313.45%
2015A$21.18104.29%
2014A$10.37100.29%
2013A$5.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.05-97.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.82 7.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.09-104.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.60-110.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
A$11.51-72.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.27-89.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
A-$8.96-121.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.67-98.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel